PMDA drug package insert
セイビスカス注
PMDA Regenerative medical product · 富士フイルム富山化学株式会社 · package insert May 8, 2026
Key facts
| Brand names | セイビスカス注 |
|---|---|
| Nonproprietary names | ヒト（自己）滑膜由来間葉系幹細胞 |
| Companies | 製造販売元／富士フイルム富山化学株式会社 |
| Product type | Regenerative medical product |
| Package insert date | May 8, 2026 |
| PMDA document key | 400022_4900X0000271_A_01 |
| PMDA company code | 400022 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: